Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05605340
Other study ID # IRB-300009275
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 9, 2023
Est. completion date May 31, 2026

Study information

Verified date August 2023
Source University of Alabama at Birmingham
Contact Amy Dobelstein
Phone 205-975-1059
Email adobelst@uabmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being done to test the feasibility, acceptability, and preliminary efficacy of a meal delivery intervention for managing gestational weight gain among pregnant women with overweight or obesity.


Recruitment information / eligibility

Status Recruiting
Enrollment 35
Est. completion date May 31, 2026
Est. primary completion date May 31, 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Gestational age = 15 weeks as assessed by ultrasound - Body mass index (BMI) = 25 kg/m2 - Singleton viable pregnancy - Receiving care and planning to deliver at UAB - Residing within the delivery radius of the meal delivery company - Wi-Fi or Bluetooth Internet connection in home (for digital Wi-Fi enabled study scale) Exclusion Criteria: - Self-reported major health conditions (e.g., heart disease, cancer, renal disease, and Type 1 or Type 2 diabetes) - Current substance abuse - Current treatment for serious psychiatric disorder (schizophrenia, bipolar disorder) - Known fetal anomaly - Planned termination of pregnancy - Past history or current diagnosis of anorexia or bulimia - Current use of one or more of the following medications: - Metformin - Systemic steroids - Antipsychotic agents - Anti-seizure medications or mood stabilizers that would be expected to have a significant impact on body weight - Medications for ADHD including amphetamines and methylphenidate - Any teratogenic agent Class D - Participation in another dietary and/or weight management intervention during pregnancy - Unwilling or unable to consume prepared meals delivered weekly - Unable to understand and communicate in verbal and written English

Study Design


Intervention

Behavioral:
Meal Delivery
10 healthy, home-delivered meals per week + brief weekly remote behavioral support

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in weight from first to last prenatal visit Weight measured at each prenatal visit will be retrieved from medical records for all participants and used to model total weight change from the first to the last prenatal visit (i.e., gestational weight gain). First prenatal visit (<15 weeks gestation), last prenatal visit (35+ weeks gestation)
Secondary Change in Food Insecurity Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days. Adult food security scores range from 0 to 10, with lower values indicating greater food security. baseline (12-15 weeks gestation), (35-36 weeks gestation)
Secondary Change in Perceived Stress Determined using the 10-item Perceived Stress Scale (PSS-10) based on the last month. PSS-10 scores range from 0 to 40, with higher scores representing higher levels of perceived stress. baseline (12-15 weeks gestation), (35-36 weeks gestation)
Secondary Change in Participant Satisfaction with Diet Determined using the 28-item Diet Satisfaction Questionnaire in which participants respond to 28 statements using a 5-point Likert scale. Responses are average to produce a total diet satisfaction score ranging from 1-5. Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning & Preparation Factor will be examined from baseline to follow-up. baseline (12-15 weeks gestation), (35-36 weeks gestation)
Secondary Proportion of Women Exceeding Institute of Medicine Gestational Weight Gain Guidelines Weight at the first prenatal visit will be subtracted from weight at the last prenatal visit. Women will be categorized as exceeding 2009 Institute of Medicine gestational weight gain guidelines if the difference is > 11.5 kg gain for women with overweight or >9 kg for women with obesity at the first prenatal visit. First prenatal visit (<15 weeks gestation), last prenatal visit (35+ weeks gestation)
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3